访问的网址不受信任
https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19
您访问的网址可能存在安全风险，我们建议您停止继续浏览该网址，以防财产损失